4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-24-003891
SVP & GENERAL COUNSEL acquired 24,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jimenez Freddy A. SVP & GENERAL COUNSEL | 2024-02-13 | Option exercise | +4,166 | $9.02 | $37,563 | 5,924 | D |
| Jimenez Freddy A. SVP & GENERAL COUNSEL | 2024-02-13 | Option exercise | +20,000 | $2.78 | $55,600 | 25,924 | D |
| Derivatives | |||||||
| Jimenez Freddy A. SVP & GENERAL COUNSEL | 2024-02-13 | Option exercise · Incentive Stock Option (Right to Buy) | −4,166 | 0 | D | ||
| Jimenez Freddy A. SVP & GENERAL COUNSEL | 2024-02-13 | Option exercise · Incentive Stock Option (Right to Buy) | −20,000 | 0 | D | ||
Loading xslF345X05/form4-02152024_090240.xml…